Patients´ recovery day 0-3 after short-stay elective surgery – a pilot study comparing desflurane and propofol TCI as main anaesthetics. - Cognitive function

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2011-000922-31-SE

Enrollment

Registered

2011-03-02

Start date

2011-04-18

Completion date

Unknown

Last updated

2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing elective general anaesthesia for breat surgery MedDRA version: 12.1 Level: LLT Classification code 10002091 Term: Anaesthesia

Interventions

Trade Name: Suprane Product Name: Suprane Pharmaceutical Form: Inhalation vapour, solution Trade Name: Propofol Product Name: Diprivan Pharmaceutical Form: Injection*

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA 1-2 females scheduled for elective breast surgery under general anaesthesia with an estimated surgical duration of 60-90 minutes Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Any cognitive or psychiatric difficiency Uncontrolled, cardiovascular, hepatic or renal disease.

Design outcomes

Primary

Measure	Time frame
Main Objective: Study recovery, resumption of cognitive capacity after end of anaesthesia;Secondary Objective: Study variability in time taken to regain cognitive capacity;Primary end point(s): Postoperative Recovery Scale score at 24 hours	—

Countries

Sweden

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026